K
Kathleen McCarroll
Researcher at Merck & Co.
Publications - 22
Citations - 983
Kathleen McCarroll is an academic researcher from Merck & Co.. The author has contributed to research in topics: Rizatriptan & Migraine. The author has an hindex of 16, co-authored 22 publications receiving 949 citations.
Papers
More filters
Journal ArticleDOI
In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends)
Flavia Rossi,Fernando Baquero,Po-Ren Hsueh,David L. Paterson,Grant V. Bochicchio,Theresa A. Snyder,Vilas Satishchandran,Kathleen McCarroll,Mark J. DiNubile,Joseph W. Chow +9 more
TL;DR: Antimicrobial resistance among GNB isolated from intra-abdominal infections continued to be a problem worldwide in 2004, with the highest rates of resistance overall in the Asia/Pacific region.
Journal ArticleDOI
Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine.
Anna R. Giuliano,Eduardo Lazcano-Ponce,Luisa L. Villa,Terry Nolan,Colin D. Marchant,David Radley,Greg Golm,Kathleen McCarroll,Jimmy Yu,Mark T. Esser,Scott Vuocolo,Eliav Barr +11 more
TL;DR: Age at vaccination initiation was inversely proportional to the vaccine-induced anti-HPV response, and data support vaccination with quadrivalent HPV vaccine across a broad range of baseline subject characteristics.
Journal ArticleDOI
Rizatriptan in the treatment of menstrual migraine
Stephen D. Silberstein,Helene Massiou,Claire Le Jeunne,Lisa Johnson-Pratt,Kathleen McCarroll,Christopher Lines +5 more
TL;DR: Rizatriptan is effective in the treatment of menstrually associated migraine attacks and was as effective in treating menstrual as well as nonmenstrual migraine.
Journal ArticleDOI
Telephone screening for amnestic mild cognitive impairment.
TL;DR: Only 2% of subjects who underwent telephone screening were recruited into the study, but 43% of those who passed telephone screening and were seen in the clinic met clinical criteria for aMCI.
Journal ArticleDOI
In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART).
Fernando Baquero,Po-Ren Hsueh,David L. Paterson,Flavia Rossi,Grant V. Bochicchio,Gale Gallagher,Keith Lantz,Javier Baez Villasenor,Kathleen McCarroll,Murray A. Abramson,Joseph W. Chow +10 more
TL;DR: In 2005, antibiotic resistance continued to be a problem among GNB isolated from intra-abdominal infections, with the highest resistance rates observed in the Asia/Pacific region.